Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Perrigo Company Plc (PRGO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7255
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutical ingredients (APIs) and infant formulas. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drug, supermarket and mass merchandise chains and direct sales representatives. The company has operations in North America, Europe, Australia and other countries including Israel and China. Perrigo is headquartered in Dublin, Ireland.

Perrigo Company Plc (PRGO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Perrigo Company Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Perrigo Company Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Perrigo Company Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Perrigo Company Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Perrigo Company Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Perrigo Company Plc, Medical Equipment, Deal Details 10
Perrigo Enters into Licensing Agreement with Merck 10
Equity Offering 11
Prothena Raises USD82.7 Million in Public Offering of Shares 11
Debt Offering 13
Perrigo Completes Private Placement Of Notes Due 2023 For US$800 Million 13
Perrigo Completes Private Placement Of Notes Due 2043 For US$400 Million 14
Perrigo Completes Private Placement Of Notes Due 2016 For US$500 Million 15
Perrigo Completes Private Placement Of Notes Due 2018 For US$600 Million 16
Acquisition 17
Perrigo Acquires 100% Stake in Gelcaps Exportadora De Mexico 17
Perrigo Completes Acquisition Of Elan 18
Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For US$36 Million 20
Perrigo Company Plc – Key Competitors 21
Perrigo Company Plc – Key Employees 22
Perrigo Company Plc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 29
Strategy And Business Planning 29
Aug 13, 2018: Perrigo plans separation of Rx business 29
Financial Announcements 31
Aug 09, 2018: Perrigo Company reports second quarter 2018 financial results 31
May 08, 2018: Perrigo Company Announces First Quarter 2018 Financial Results 33
Mar 01, 2018: Perrigo Company Reports Fourth Quarter & Calendar Year 2017 Financial Results 35
Feb 27, 2018: Perrigo Company Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results 37
Nov 09, 2017: Perrigo Company Reports Third Quarter 2017 Financial Results 38
Aug 10, 2017: Perrigo Company Reports Second Quarter 2017 Financial Results 40
Corporate Communications 41
Oct 08, 2018: Perrigo appoints Murray S. Kessler as President And Chief Executive Officer In line with shift To consumer-focused strategy 41
Feb 20, 2018: Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Perrigo Company Plc, Medical Equipment, Key Facts, 2017 2
Perrigo Company Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Perrigo Company Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Perrigo Company Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Perrigo Company Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Perrigo Company Plc, Deals By Market, 2012 to YTD 2018 8
Perrigo Company Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Perrigo Enters into Licensing Agreement with Merck 10
Prothena Raises USD82.7 Million in Public Offering of Shares 11
Perrigo Completes Private Placement Of Notes Due 2023 For US$800 Million 13
Perrigo Completes Private Placement Of Notes Due 2043 For US$400 Million 14
Perrigo Completes Private Placement Of Notes Due 2016 For US$500 Million 15
Perrigo Completes Private Placement Of Notes Due 2018 For US$600 Million 16
Perrigo Acquires 100% Stake in Gelcaps Exportadora De Mexico 17
Perrigo Completes Acquisition Of Elan 18
Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For US$36 Million 20
Perrigo Company Plc, Key Competitors 21
Perrigo Company Plc, Key Employees 22
Perrigo Company Plc, Subsidiaries 23

List of Figures
Perrigo Company Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Perrigo Company Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Perrigo Company Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Perrigo Company Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Perrigo Company Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Perrigo Company Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Perrigo Company Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Perrigo Company Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Bin Qasim Ltd (FFBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • ClearOne Inc (CLRO):企業の財務・戦略的SWOT分析
    Summary ClearOne Inc (ClearOne) formerly ClearOne Communications Inc, is a technology company that provides conferencing, collaboration, streaming, and digital signage solutions. The company provides professional conferencing, audio and video distribution, premium conferencing, tabletop conferencing …
  • CHS Inc (CHSCP):石油・ガス:M&Aディール及び事業提携情報
    Summary CHS Inc. (CHS) is an integrated agribusiness company, which provides grain, foods and energy resources to businesses and consumers. It is a cooperative owned by farmers and ranchers and their member cooperatives across the US. The company provides a broad range of products and services, from …
  • Monteloeder S.L.:戦略・SWOT・企業財務分析
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Filtration Group Corp:企業の戦略的SWOT分析
    Filtration Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BioTime Inc (BTX):企業の製品パイプライン分析2018
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Sany Group Co Ltd:企業の戦略・SWOT・財務情報
    Sany Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sany Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fugro NV (FUR):企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …
  • Essar Power Ltd:企業の戦略的SWOT分析
    Essar Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Blueprint Medicines Corp (BPMC)-医療機器分野:企業M&A・提携分析
    Summary Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-285, for treatment resistant gastrointestinal stromal …
  • Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報
    Summary Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care …
  • SAP SE:企業の戦略・SWOT・財務情報
    SAP SE - Strategy, SWOT and Corporate Finance Report Summary SAP SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Koninklijke Philips N.V. (PHIA)-製薬・医療分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Abbott Laboratories (ABT):医療機器:M&Aディール及び事業提携情報
    Summary Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; mi …
  • Wintac Ltd (524758):企業の財務・戦略的SWOT分析
    Summary Wintac Ltd (Wintac), formerly Recon Ltd is a manufacturer and marketer of sterile products. The company offers opthalmic products such as anti-glaucoma, anti-cholinergic, artificial tear, NSAID, steroids and combination, anti-infective, decongestant, anti allergic eye drops and nasal drop, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆